Scorpio Biosolutions Profile
Key Indicators
- Authorised Capital ₹ 3.60 Cr
- Paid Up Capital ₹ 3.55 Cr
- Company Age 24 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 88.00 Cr
- Satisfied Charges ₹ 38.08 Cr
- Revenue Growth -48.61%
- Profit Growth -61.23%
- Ebitda -31.41%
- Net Worth 14.75%
- Total Assets 71.72%
About Scorpio Biosolutions
Scorpio Biosolutions Private Limited (SBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 22 February 2000 and has a history of 24 years and 11 months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.60 Cr and a paid-up capital of Rs 3.55 Cr.
The company currently has active open charges totaling ₹88.00 Cr. The company has closed loans amounting to ₹38.08 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jyothi Chintalapati and Vaishnavi Chintalapati serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U01110TG2000PTC033642
-
Company No.
033642
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Feb 2000
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Scorpio Biosolutions?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Jyothi Chintalapati | Director | 27-Aug-2011 | Current |
Vaishnavi Chintalapati | Director | 11-Feb-2021 | Current |
Financial Performance of Scorpio Biosolutions.
Scorpio Biosolutions Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 48.61% decrease. The company also saw a substantial fall in profitability, with a 61.23% decrease in profit. The company's net worth Soared by an impressive increase of 14.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Scorpio Biosolutions?
In 2023, Scorpio Biosolutions had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹88.00 Cr
₹38.08 Cr
Charges Breakdown by Lending Institutions
- Tata Capital Financial Services Limited : 60.00 Cr
- Others : 28.00 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
06 Oct 2023 | Others | ₹28.00 Cr | Open |
27 Feb 2023 | Tata Capital Financial Services Limited | ₹60.00 Cr | Open |
25 Aug 2022 | Others | ₹23.00 Cr | Satisfied |
08 Sep 2011 | Indian Overseas Bank | ₹12.65 Cr | Satisfied |
18 May 2005 | Oriental Bank Of Commerce | ₹5.25 M | Satisfied |
How Many Employees Work at Scorpio Biosolutions?
Unlock and access historical data on people associated with Scorpio Biosolutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Scorpio Biosolutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Scorpio Biosolutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.